Global vascular imaging market was worth USD 17.5 billion in 2018. It is expected to grow at a 4.2% CAGR by 2026. Rising prevalence of hypertension, hypercholesterolemia, and diabetes is the major factor expected to contribute towards the market growth over the forecast period. These conditions can increase the risk for vascular disorders like aneurysms and carotid blockage as well as deep vein thrombosis and atherosclerosis. This is where the majority of vascular imaging devices are most useful.
The factors that are expected to have a positive impact on the demand for vascular imaging procedures in both developed and developing countries include a growing awareness of early diagnosis and intervention to reduce mortality or morbidity, as well as rising adoption of preventive healthcare methods. The market is expected to grow due to technological advances that aim to make diagnosis safer and more efficient with minimal turnaround times. Advanced CT scanners that combine sensitive detectors and dual sources can scan efficiently and quickly at low radiation exposure. This improves patient satisfaction.
The market is expected to grow due to increased use of vascular imaging modalities for trauma cases, as well as pre, post and intraoperative procedures. Pre-operative coronary imaging can be used to determine if stenting is necessary, while post-operative images can provide information on the effectiveness of cardiac grafts and stenting.
The forecast period will see an increase in noninvasive diagnostic imaging techniques, a rising tendency towards minimally invasive procedures, and the establishment efficient clinical guidelines. The National Institute for Health and Care Excellence's clinical guidelines recommend CT coronary angiography to be used as a first-line procedure for patients with stable chest pain.
The market for vascular imaging can be divided into two types based on its type: minimally invasive or non-invasive. The minimally invasive segment is divided into intravascular ultrasound, catheter angiogram and computed tomography-angiography (CTA), lymphoscintigraphy and venogram. Non-invasive segments are classified as abdominal ultrasound, angiography (ABI), ankle-brachial scan (CTA), captopril kidney scan, carotid Duplex ultrasound (CT scan), Doppler ultrasound (duplex ultrasound), MRA (magnetic radiation angiography) or MRI (magnetic imaging).
The market share for non-invasive imaging was the largest in 2018, and it is expected to continue growing at a healthy pace over the forecast period. The market is expected to grow due to its safety and patient convenience. It takes minimally invasive vascular imaging several hours to recover the catheter insertion site, while patients who have undergone a coronary CT can return to their normal activities immediately.
The adoption of advanced vascular imaging techniques will increase if specificity, sensitivity and imaging standards are improved. A clinical study published in NCBI found that CT coronary angiography was more sensitive than conventional invasive angiography and had a higher specificity and sensitivity (80.0% and 67.0%, respectively) in diagnosing Coronary Heart Diseases.
The vascular imaging market can be divided into two segments based on end-use: hospitals and diagnostics imaging centers. The largest market share was held by hospitals in 2018, and they are expected to continue growing at a rapid pace over the forecast period. This segment's growth is largely due to factors like a large patient pool, the availability of funds to purchase advanced equipment, and high competition among healthcare service provider providers.
A rising number of hospital emergency admissions for conditions like stroke, chest pain and abdominal discomfort will likely increase the demand for vascular imaging techniques in emergency departments. According to NCBI, acute chest pain accounts for over 700,000 emergency department admissions each year in England and Wales. This is approximately one-fourth the number of emergency admissions. To avoid complications, this condition must be diagnosed quickly and accurately. Their use in emergency departments, including ambulatory care centers, will be expanded by the introduction of faster and handheld imaging equipment.
The growth of diagnostic imaging centers is also anticipated to be significant over the forecast period. Growth is expected to be driven by the low cost of CT/ MRI scans and the existence of diagnostics accreditation boards.
The market can be divided into therapeutic and diagnostic segments based on its application. 2018 saw the highest share for diagnostics. The segment's growth is due to the introduction of advanced imaging technologies that reduce turnaround times and the development of more effective diagnostic modalities.
The development of targeted therapies that are more effective, adapting preventive measures and the introduction early diagnostic methods that aid in increasing treatment success during the early stages of disease are some of the factors expected to hinder the growth of this therapeutic segment. The introduction of advanced technology, such as vascular robotics and the centrally inserted peripheral venous catheter, is expected to eliminate complications related to repeat procedures and blood vessel breakage.
In 2018, North America accounted for the largest market share in vascular imaging. This region is expected to grow due to the presence of major players and streamlined reimbursement policies. The rising incidence of strokes and the prevalence of cardiovascular diseases are also factors. AHA 2019 stroke and heart disease statistics show that an average of 40 seconds per American will suffer from a stroke. In addition, approximately 795,000 Americans are affected by recurrent or new strokes each year.
Europe was the second largest market for vascular imaging in 2019, accounting for a quarter of all global sales. The growth is expected to be fueled by rising rates of obesity, diabetes, and other cardiovascular diseases. This is due in part to increasing behavioral risk factors like smoking, alcohol consumption and unhealthy lifestyles. Most of the MRI and vascular CT units in the region are older than 10 years. The market dynamics for the region will be boosted by the replacement of older equipment with more advanced models during the forecast period.
Asia Pacific is expected to grow at the fastest rate of CAGR during the forecast period. The region's growth is driven by several factors: large patient pools, increasing presence of international healthcare service providers, and rising government support. Japan, India and China are the major markets in this region. South Korea is also a key market.
There are many players in this market, including Siemens Healthineers and GE Healthcare. These companies are focused on growth strategies such as product launches, innovation in existing technologies and devices and mergers and acquisitions. Partnerships, geographic expansion and more are some of the options. Recent acquisitions by Siemens Healthineers of Corindus Vascular Robotics were completed. This acquisition will allow Siemens Healthineers to increase its offering in interventional vascular imaging.
GE Healthcare, a major player in the industry, has developed Revolution Apex, a modernized ultrapremium CT scanner. The system offers enhanced visual coverage, spectral image options, spatial resolution and temporal resolution all in one. Quantix 160 Tube is integrated into the system. This tube offers next-level performance and excellent picture quality for both current and future patients. Revolution Apex has been proven to be beneficial for patients with high heart rates, impaired renal function, high body weight, and other conditions.
Attribute |
More Details |
Base year for estimation |
2018 |
Actual estimates/Historical data |
2015 - 2017 |
Forecast period |
2019 - 2026 |
Representation of the market |
From 2019 to 2026, revenue in USD million and CAGR |
Regional scope |
North America, Europe and Asia Pacific, Latin America and the Middle East & Africa |
Country coverage |
U.S., Canada, UK, Germany, France, Italy, Spain, China, India, Japan, Thailand, South Korea Mexico, Brazil, Colombia, Argentina, South Africa, Saudi Arabia, UAE |
Report coverage |
Forecast revenue, company share, competitive landscape and growth factors and trends |
15% off customization scope (equivalent of 5 analyst working days). |
We will customize the report to provide you with specific market information that is not included in the current report. |
This report predicts revenue growth at the global, regional and country levels. It also analyzes the industry trends for each sub-segment from 2015 to 2026. Grand View Research has divided the global vascular imaging market by type, region, end-use, and application.
Type Outlook (Revenue in USD million, 2015-2026)
Minimally Invasive
Catheter angiogram
CTA
Lymphoscintigraphy
Venogram
Intravascular ultrasound
Non-invasive
Ultrasound abdominally
Angiography
Ankle-brachial Index (ABI).
Renal scan with Captopril
Carotid duplex ultrasound
CT scan
Doppler ultrasound
Duplex ultrasound
MRA (magnetic resonance angiography)
MRI (magnetic radiation imaging)
Application Outlook (Revenues, SD Million, 2015-2026)
Diagnostic
Therapeutic
End-use Outlook (Revenue USD Million; 2015-2026)
Hospitals
Diagnostic Imaging Centers
Other
Regional Outlook (Revenue USD Million, 2015-2026)
North America
The U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Asia Pacific
China
Japan
India
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Up Market Research published a new report titled “Vascular Imaging Market research report which is segmented by Type (Non-Invasive, Invasive), by End-Use (Hospitals, Diagnostic imaging centers), by Application (Diagnostic, Therapeutic), By Players/Companies  and Carestream Health Inc These players are focusing on adopting growth strategies, GE Healthcare, Siemens Healthineers completed the acquisition of Corindus Vascular Robotics This is expected to expand its portfolio of interventional vascular imaging, innovations in the existing technologies and devices, Abbott Laboratories, geographical expansion, Koninklijke Philips NV Hitachi Medical Corporation, mergers and acquisitions, such as new product launches, Siemens Healthineers, partnerships, Samsung Medison, more Recently, Hologic Inc, Shimadzu Medical Systems”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Vascular Imaging Market Research Report |
By Type | Non-Invasive, Invasive |
By End-Use | Hospitals, Diagnostic imaging centers |
By Application | Diagnostic, Therapeutic |
By Companies | Â and Carestream Health Inc These players are focusing on adopting growth strategies, GE Healthcare, Siemens Healthineers completed the acquisition of Corindus Vascular Robotics This is expected to expand its portfolio of interventional vascular imaging, innovations in the existing technologies and devices, Abbott Laboratories, geographical expansion, Koninklijke Philips NV Hitachi Medical Corporation, mergers and acquisitions, such as new product launches, Siemens Healthineers, partnerships, Samsung Medison, more Recently, Hologic Inc, Shimadzu Medical Systems |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 225 |
Number of Tables & Figures | 158 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type (Non-Invasive, Invasive), by End-Use (Hospitals, Diagnostic imaging centers), by Application (Diagnostic, Therapeutic).
Vascular Imaging Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Vascular Imaging Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Vascular Imaging Market Report:
Some other reports from this category!